It remains unknown whether increased risk with low levels of vitamin D is present for colon and/or rectal cancer. To investigate the association between circulating vitamin D levels and colon and rectal cancer, we examined the associations between plasma levels of 25- 
and ("cohort" or "case-control" or "case-cohort" or "epidemiology") and ("cancer")). The search was restricted to human studies published in English-language articles. We also examined references from these publications to identify further studies. We identified nine studies (7) (8) (9) (10) (11) (12) (13) (14) 18 ) that examined serum or plasma 25(OH)D and colorectal cancer incidence in a prospective design (blood drawn prior to diagnosis of cancer). We contacted authors of three papers (10-12, 18) that did not report results for colon and rectal cancer separately. One study provided the odds ratios (ORs) and 95% confidence intervals (95% CIs) for rectal cancer, but not for colon cancer (10). Another study provided the ORs and 95% CIs for both colon and rectal cancers (12). Two reports from the CLUE cohort reported results for only colon cancer using the same dataset with different time periods (1975-1983 and 1984-1991) (11, 18) . As a result, we included in this meta-analysis a total of seven published individual prospective studies of colon 6 cancer (7-9, 11-14, 18) and seven studies of rectal cancer (7) (8) (9) (10) (12) (13) (14) , plus the present data from the Physicians' Health Study.
Statistical Analyses
In the Physicians' Health Study, to estimate ORs and 95% CIs, participants were categorized into quartiles based on plasma vitamin D metabolite levels among the controls. To remove the variation in vitamin D metabolites due to season of blood collection, we regressed plasma 25(OH)D or 1,25(OH)2D on the periodic functionsin(2ΠX/12)-cos(2ΠX/12), where X is the month of sample collection (19) . The residuals from this model were added to the ethnic-specific plasma 25(OH)D means (Caucasian or non-Caucasian). We used a conditional logistic regression model to account for the matched case-control study design. To test for trend across quartiles, participants were assigned the median value of their quartile level. This variable was entered as a continuous term in the model, the coefficient for which was evaluated by the Wald test.
In the multivariate analyses, we adjusted for season of blood collection (winter/spring, summer/autumn), ethnicity (Caucasian, non-Caucasian), fasting status (≤8, > 8 hours), body mass index (BMI; <23, 23-<25, 25-<27, ≥27 kg/m 2 ), dairy calcium intake (≤146, 146<-340, 340<-580, ≥580 mg/d), and vigorous exercise (<1, 1-4 times/wk, ≥5 times/wk).
The study was analyzed with the SAS 9.1 statistical package (SAS Institute, Cary, NC).
For the meta-analysis, we used a random effects model developed by DerSimonian and Laird (20) . The individual study estimates were weighted by the inverse of their variance. We tested for heterogeneity between studies using the Q statistic (20 
Results
In the Physicians' Health Study, plasma 25(OH)D levels were higher among men who took multivitamins, regularly exercised, and provided blood samples during summer/autumn. Plasma 1,25(OH)2D levels were higher among men who consumed moderate alcohol and provided blood samples during summer/autumn (data not shown).
The median follow-up time from baseline to diagnosis of colorectal cancer was 8.9 years.
We found no significant association between plasma 25(OH)D and overall colorectal cancer risk (Table 1) . When we examined colon cancer and rectal cancer separately, a suggestive inverse association was observed for rectal cancer with a threshold effect (ORs for each subsequent quartile vs. 1 st quartile of plasma 25(OH)D were 0.53, 0.42, 0.45; P for trend = 0.05), but not for colon cancer. We also observed a suggestive inverse trend for 1,25(OH)2D and risk of colorectal cancer but neither the point estimates or the P for trends were statistically significant for overall colorectal or site-specific cancers (Table 1) .
We conducted a meta-analysis of the associations between circulating 25(OH)D levels and colorectal cancer in eight prospective studies ( Figure 1A 
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previous studies plus the present data from the Physicians' Health Study (Table 2) . We found a stronger inverse association for rectal cancer than colon cancer, although a formal test for difference between colon and rectal cancers was not statistically significant (P for difference = 0.20). The pooled multivariate OR was 0.77 (95% CI = 0.56-1.07; P for heterogeneity between studies = 0.04; Figure 1B ) for colon cancer and 0.50 (95% CI = 0.28-0.88; P for heterogeneity between studies = 0.04; Figure 1C 
Discussion
In the Physicians' Health Study, we found an inverse trend of circulating blood 25(OH)D levels with rectal cancer risk, which was in line with the results from some of the previous studies that reported a significant inverse association or trend for rectal cancer (7, (12) (13) (14) . By combining results from the Physicians' Health Study and the previous seven prospective studies, a meta-analysis of eight prospective studies support a stronger inverse association of circulating blood 25(OH)D levels with rectal cancer risk than with colon cancer risk. Statistically non-significant difference warrants more prospective studies of circulating vitamin D levels and colon and rectal cancers and additionally distal and proximal cancers. 
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Etiologic differences between colon and rectal cancer, such as differences in the associations with life style modifiers, prevalence of specific gene mutations, and expression levels of specific genes, are commonly described (22) (23) (24) . In a clinical study that examined vitamin D deficiency among 221 colon cancer and 94 rectal cancer patients, severe vitamin D deficiency (defined as ≤ 15 ng/mL) was more common among rectal cancer patients than colon cancer patients (25) . Several studies reported difference in associations for vitamin D receptor polymorphisms and calcium or vitamin D by tumor sites. The SS genotype of poly(A) mononucleotide repeat and BB genotype of BsmI were associated with a reduced risk of rectal cancer, not with colon cancer in the presence of low calcium and low energy (26) . There is evidence that the associations for calcium and vitamin D were stronger for more distal and rectal tumors than proximal colon tumors (26) (27) . Also, in a study of molecular marker in rectal tumors, the associations of vitamin D intake and vitamin D receptor polymorphism with TP53 mutation status were present in rectal tumors (28) . These studies further suggest a possible difference in vitamin Drelated mechanisms in the pathogenesis of rectal cancer compared with colon cancer.
The lack of a significant inverse association in the Physicians' Health Study between circulating 25(OH)D levels and colon cancer may be because the association of 25(OH)D is weaker for colon cancer or because most of our blood samples (>70 %) were collected during summer/autumn, which may not fully capture differences in levels throughout the year. One study that examined the associations across seasons found that an inverse association was limited to those whose blood samples were collected during Only three prospective studies examined the association of circulating 1,25(OH)2D levels with risk of colorectal cancer or colon cancer (7, 14, 18) , and our meta-analysis, including the Physicians' Health Study, suggests no association. This may be because 1,25(OH)2D is more tightly regulated largely by renal 1-α-hydroxylase activity (29) . 
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residual confounding because our study did not allow us to adjust for cumulative information on covariates across follow-up time. However, we found no appreciable change in the associations after adjusting for various measured risk factors, suggesting that residual confounding by risk factors may not explain the association observed in the Physicians' Health Study. Heterogeneity across studies in a meta-analysis may be due to differences in laboratory measurement methods, follow-up periods, seasons of blood draw, exposure to sun light, ethnicity, and prevalence of other interaction factors and unknown/unmeasured confounding factors. Important strengths of our study and metaanalysis include the prospective design in which blood samples were collected before cancer diagnosis.
Taken together, these prospective results support the hypothesis that vitamin D is inversely related to colorectal cancer risk, and that vitamin D is more strongly associated with reduced risk of rectal cancer than colon cancer.
Cancer Research. *Among control participants, quartile cutoff points were determined by season (summer/autumn or winter/spring) and batches (two batches). † Matched on age (±1 year for younger participants, ±5 years for older participants) and smoking status (never, past, current). ‡ Matched on age (±1 year for younger participants, ±5 years for older participants) and smoking status (never, past, current). Further adjusted for seasons (summer/autumn or winter/spring), fasting status (≤8, > 8 hours), race (Caucasian or non-Caucasian), vigorous exercise (<1, 1-4 times/wk, ≥5 times/wk), dairy calcium intake (≤146, 146<-340, 340<-580, ≥580 mg/d), and body mass index (<23, 23-<25, 25-<27, ≥27 kg/m 
